The development of drugs for treatment of sleeping sickness: a historical review
- PMID: 20219092
- PMCID: PMC2848007
- DOI: 10.1186/1756-3305-3-15
The development of drugs for treatment of sleeping sickness: a historical review
Abstract
Only four drugs are available for the chemotherapy of human African trypanosomiasis or sleeping sickness; Suramin, pentamidine, melarsoprol and eflornithine. The history of the development of these drugs is well known and documented. suramin, pentamidine and melarsoprol were developed in the first half of the last century by the then recently established methods of medicinal chemistry. Eflornithine, originally developed in the 1970s as an anti-cancer drug, became a treatment of sleeping sickness largely by accident. This review summarises the developmental processes which led to these chemotherapies from the discovery of the first bioactive lead compounds to the identification of the final drugs.
Figures
Similar articles
-
Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.Parasitol Res. 2003 May;90(1):71-9. doi: 10.1007/s00436-002-0799-9. Epub 2003 Jan 31. Parasitol Res. 2003. PMID: 12743807 Review.
-
[Agents for the treatment of African sleeping sickness. Those developed in the last century].Pharm Unserer Zeit. 2009;38(6):552-8. doi: 10.1002/pauz.200900344. Pharm Unserer Zeit. 2009. PMID: 19862727 Review. German. No abstract available.
-
Chemotherapy for second-stage Human African trypanosomiasis.Cochrane Database Syst Rev. 2010 Aug 4;(8):CD006201. doi: 10.1002/14651858.CD006201.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2013 Jun 28;(6):CD006201. doi: 10.1002/14651858.CD006201.pub3. PMID: 20687080 Updated. Review.
-
Current chemotherapy of human African trypanosomiasis.Parasitol Res. 2003 Jun;90 Supp 1:S10-3. doi: 10.1007/s00436-002-0752-y. Epub 2002 Nov 23. Parasitol Res. 2003. PMID: 12811544 Review.
-
Drug resistance in human African trypanosomiasis.Future Microbiol. 2011 Sep;6(9):1037-47. doi: 10.2217/fmb.11.88. Future Microbiol. 2011. PMID: 21958143 Review.
Cited by
-
Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.Pharmaceutics. 2024 Sep 24;16(10):1239. doi: 10.3390/pharmaceutics16101239. Pharmaceutics. 2024. PMID: 39458571 Free PMC article. Review.
-
DFMO inhibition of neuroblastoma tumorigenesis.Cancer Med. 2024 May;13(9):e7207. doi: 10.1002/cam4.7207. Cancer Med. 2024. PMID: 38686627 Free PMC article.
-
Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies.Int J Parasitol Drugs Drug Resist. 2024 Aug;25:100533. doi: 10.1016/j.ijpddr.2024.100533. Epub 2024 Mar 30. Int J Parasitol Drugs Drug Resist. 2024. PMID: 38555795 Free PMC article. Review.
-
Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy.J Med Chem. 2024 Feb 22;67(4):2849-2863. doi: 10.1021/acs.jmedchem.3c01976. Epub 2024 Feb 8. J Med Chem. 2024. PMID: 38330051 Free PMC article.
-
Tractable Quinolone Hydrazides Exhibiting Sub-Micromolar and Broad Spectrum Antitrypanosomal Activities.ChemMedChem. 2024 May 2;19(9):e202300667. doi: 10.1002/cmdc.202300667. Epub 2024 Feb 23. ChemMedChem. 2024. PMID: 38326914 Free PMC article.
References
-
- Molyneux DH, Pentreath V, Doua F. In: Manson's Tropical Diseases. 20. Cook GC, editor. London: W.B. Saunders; 1996. African trypanosomiasis in man; pp. 1171–1196.
-
- World Health Organization. Control of human African trypanosomiasis: a strategy for the African region. 2005. AFRO, AFR/RC55/11.
-
- World Health Organization. African trypanosomiasis (sleeping sickness) World Health Organ Fact Sheet. 2006. p. 259.http://www.who.int/mediacentre/factsheets/fs259/en/
LinkOut - more resources
Full Text Sources